Cat. No.: DIA-0230484
Product Information | |
---|---|
CAS No. | 1640292-55-2 |
Synonyms | PF-03394197 |
Formula | C19H27N5O6S |
Molecular Weight | 453.51 |
SMILES | CN[S](=O)(=O)CC1CCC(CC1)N(C)C2=C3C=C[NH]C3=NC=N2.OC(=O)\C=C/C(O)=O |
Product Description | Oclacitinib(PF 03394197) is a novel inhibitor of JAK family members with IC50 ranging from 10 to 99 nM and JAK1-dependent cytokines with IC50 ranging from 36 to 249 nM. It does not inhibit a panel of 38 non-JAK kinases. |
Format & Storage | |
---|---|
Purity | > 98% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.